Isogenica will be attending Bio-Europe and will be represented by CEO Emma Sceats and Commercial Cirector Adam collier. This will be an exciting opportunity for us to talk to potential partners about Isogenicas accelerating therapeutic antibody discovery through our state-of-the-art synthetic antibody libraries.

 

Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. to highlight any interest to meet in advace of our attendance. 

  

https://ebdgroup.knect365.com/bioeurope/